New York, NY & Tel Aviv, Israel, Sept. 19, 2021 (GLOBE NEWSWIRE) — (by way of Blockchain Wire) Todos Medical, Ltd. (OTCQB: TOMDF), a medical diagnostics and options firm with complete product choices, introduced that it’s now accepting Bitcoin (BTC), Ethereum (ETH), Dogecoin (DOGE), Bitcoin Money (BCH) and Litecoin (LTC) as cost for the Firm’s proprietary 3CL protease inhibitor wellness merchandise Tollovid® and Tollovid Each day™. The Firm is ready to settle for these types of funds by means of its www.mytollovid.com web site when purchasers choose Coinbase Commerce because the type of cost at checkout.
“We consider strongly that everybody ought to take Tollovid to help their immune operate throughout occasions of great immune problem and ought to be taking Tollovid Each day each day in an effort to keep constant, wholesome immune operate,” stated Gerald E. Commissiong, President & CEO of Todos Medical. “The power to just accept extensively utilized cryptocurrency is a vital step as we broaden our advertising and marketing efforts round our novel 3CL protease inhibitor wellness merchandise.”
Tollovid and Tollovid Each day are dietary complement merchandise which have each obtained Certificates of Free Sale from the U.S. Meals & Drug Administration (FDA), authorizing the advertising and marketing and sale of those merchandise in america. The FDA has allowed the Firm to make two particular claims with reference to every product:
- Tollovid and Tollovid Each day assist to help and keep wholesome immune operate; and
- Tollovid and Tollovid Each day are 3CL protease inhibitors.
Tollovid is focused to clients that want most immune help, whereas Tollovid Each day addresses clients that require or may benefit from every day immune help. Each Tollovid and Tollovid Each day may be bought by way of subscription and now, using cryptocurrency
About Todos Medical Ltd.
Based in Rehovot, Israel with places of work in New York Metropolis, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic options for the early detection of a wide range of cancers. In 20201, Todos accomplished the acquisition of U.S.-based medical diagnostics firm Provista Diagnostics, Inc. to realize rights to its Alpharetta, Georgia-based CLIA/CAP licensed lab at present performing PCR COVID testing and Provista’s proprietary commercial-stage Videssa® breast most cancers blood check. The Firm’s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening know-how utilizing peripheral blood evaluation that deploys deep examination into most cancers’s affect on the immune system, on the lookout for biochemical modifications in blood mononuclear cells and plasma. Todos’ two internally-developed cancer-screening checks, TMB-1 and TMB-2, have obtained a CE mark in Europe. Todos is concentrated on the commercialization of Videssa and can deliver the TBIA checks to market thereafter.
Todos has entered right into a three way partnership with NLC Pharma concentrating on diagnostic and testing options to deal with the COVID-19 pandemic. The Joint-Enterprise is pursuing the event of diagnostic checks concentrating on the 3CL protease, in addition to 3CL protease inhibitors that concentrate on a basic reproductive mechanism of coronaviruses. The Firm’s proprietary therapeutic candidate Tollovir™ is at present in a Part 2 medical trial to deal with hospitalized COVID-19 sufferers in Israel, and is making ready to provoke Part 2/3 medical trials for each hospitalized and non-hospitalized sufferers in Israel.
Todos can also be creating blood checks for the early detection of neurodegenerative problems, reminiscent of Alzheimer’s illness. The Lymphocyte Proliferation Check (LymPro Check™) is a diagnostic blood check that determines the flexibility of peripheral blood lymphocytes (PBLs) and monocytes to resist an exogenous mitogenic stimulation that induces them to enter the cell cycle. It’s believed that sure illnesses, most notably Alzheimer’s illness, are the results of compromised mobile equipment that results in aberrant cell cycle re-entry by neurons, which then results in apoptosis. LymPro is exclusive in the usage of peripheral blood lymphocytes as a surrogate for neuronal cell operate, suggesting a standard relationship between PBLs and neurons within the mind.
Todos can also be distributing sure (COVID-19) testing supplies and provides to CLIA-certified labs in america. The merchandise cowl a number of suppliers of PCR testing kits, extraction kits, automation supplies and provides, in addition to COVID-19 antibody and antigen testing kits.
For extra info, please go to https://www.todosmedical.com
Sure statements contained on this press launch could represent forward-looking statements. For instance, forward-looking statements are used when discussing our anticipated medical growth packages and medical trials. These forward-looking statements are based mostly solely on present expectations of administration, and are topic to important dangers and uncertainties that might trigger precise outcomes to vary materially from these described within the forward-looking statements, together with the dangers and uncertainties associated to the progress, timing, value, and outcomes of medical trials and product growth packages; difficulties or delays in acquiring regulatory approval or patent safety for product candidates; competitors from different biotechnology firms; and our means to acquire extra funding required to conduct our analysis, growth and commercialization actions. As well as, the next elements, amongst others, may trigger precise outcomes to vary materially from these described within the forward-looking statements: modifications in know-how and market necessities; delays or obstacles in launching our medical trials; modifications in laws; incapacity to well timed develop and introduce new applied sciences, merchandise and purposes; lack of validation of our know-how as we progress additional and lack of acceptance of our strategies by the scientific group; incapacity to retain or appeal to key workers whose data is important to the event of our merchandise; unexpected scientific difficulties which will develop with our course of; larger value of ultimate product than anticipated; lack of market share and stress on pricing ensuing from competitors; and laboratory outcomes that don’t translate to equally good leads to actual settings, all of which may trigger the precise outcomes or efficiency to vary materially from these contemplated in such forward-looking statements. Besides as in any other case required by regulation, Todos Medical doesn’t undertake any obligation to publicly launch any revisions to those forward-looking statements to replicate occasions or circumstances after the date hereof or to replicate the incidence of unanticipated occasions. For a extra detailed description of the dangers and uncertainties affecting Todos Medical, please confer with its reviews filed every now and then with the U.S. Securities and Alternate Fee.
Richard Galterio Todos Medical, Ltd 732-642-7770 firstname.lastname@example.org Daniel Hirsch Todos Medical, Ltd 347-699-0029 email@example.com https://www.todosmedical.com